Hematologic Diseases: Clinical Trials

486 trials for Hematologic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

486 completed. 486 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4486Completed 486

Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases

Trials (filtered) newest first · largest first

All 486 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy
INTRAVENOUS FERRIC CARBOXYMALTOSE, oral iron therapy - Postpartum Fatigue, Iron Deficiency Anemia
Phase 4CompletedPakistan Air Force (PAF) Hospital Islamabad1342026-04-202026-10-19
Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Phase 4CompletedNovartis Pharmaceuticals852024-11-282026-06-08
Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia
Tablet Metformin (Group A), Tablet Hydroxyurea (Group B) - Transfusion Dependent Beta-thalassemia
Phase 4CompletedBahria University962024-09-162026-04-28
Clinical Study of Combined Platelet Transfusion
Combined platelets - Hematologic Diseases
Phase 4CompletedThe General Hospital of Western Theater Command2662024-08-012026-09-11
Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia
ciprofol - Hypoproteinemia, Pharmacokinetics
Phase 4CompletedXie Kangjie362024-04-042025-10-01
Optimizing Dosing Strategies in Oral Iron Supplementation
Tardyferon - Iron Deficiencies, Iron Deficiency Anemia
Phase 4CompletedLuzerner Kantonsspital292024-03-012026-01-07
BenRalizumab Effect on Airway Remodeling in Severe asTHma
Benralizumab 30 mg/ml - Asthma; Eosinophilic, Airway Remodeling
Phase 4CompletedAristotle University Of Thessaloniki362024-03-012026-10-28
Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
Comparison short vs extended EBAT treatment group - Neutropenia, Febrile
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven4502024-02-262026-10-23
Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
Iron Carboxymaltose, Iron Sucrose Injection - Iron Deficiency Anemia (IDA), Pregnancy
Phase 4CompletedCMH Multan Institute of Medical Sciences602024-02-012025-04-06
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Bridion 200 MG in 2 ML Injection, Pyridostigmine Bromide 5 MG/ML - Emergence Delirium, Strabismus
Phase 4CompletedKonkuk University Medical Center762023-12-012026-07-15
The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures
Ferric carboxymaltose - Hip Fractures, Anemia
Phase 4CompletedIstanbul University2092023-10-102025-03-26
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
Unfractionated heparin, Double-legged cycle ergometer exercise, Single-legged cycle ergometer exercise, with unfractionated heparin injection in the exercising leg - Blood Coagulation Disorder
Phase 4CompletedKristian Karstoft232023-09-222024-06-26
CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly
Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit - Aplastic Anemia
Phase 4CompletedPeking Union Medical College Hospital862023-09-152025-04-30
Bridging the Healing Gap: A Single-Blind Clinical Trial Assessing the Efficacy of Carboxy-gel in Reducing Bruising and Pain Post-Liposuction
Carboxytherapy, Placebo - Liposuction, Bruising
Phase 4CompletedTotal Definer Research Group722023-09-012026-07-21
Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients
N acetyl cysteine, Placebo - Linezolid, Antioxidant
Phase 4CompletedHelwan University2502023-08-012025-07-14
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
Daprodustat - Anemia, Renal Insufficiency, Chronic
Phase 4CompletedUSRC Kidney Research1612023-07-012024-05-24
Preoperative Monoferric for Abdominal Surgery
Monoferric - Anemia, Surgery
Phase 4CompletedBrigham and Women's Hospital372023-04-182026-08-26
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
Traditional Cryoprecipitate, Pathogen-Reduced Cryoprecipitate - Hypofibrinogenemia, Bleeding
Phase 4CompletedWeill Medical College of Cornell University2082023-04-012025-11-21
Prevention of Cefoperazone-induced Coagulopathy
Vitamin K - Antibiotic Side Effect
Phase 4CompletedHelwan University562023-02-252023-10-10
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
inotuzumab ozogamicin - Acute Lymphoblastic Leukemia
Phase 4CompletedPfizer442023-02-242025-12-03

Showing 20 of 486. Sign in to see all of them.

Narrower conditions

Anemia (118)  ·  Anemia, Iron-Deficiency (47)  ·  Hemophilia A (38)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (30)  ·  Multiple Myeloma (22)  ·  Renal Insufficiency, Chronic (22)  ·  Leukemia (20)  ·  Leukemia, Myeloid, Acute (19)  ·  Iron Deficiencies (18)  ·  Neoplasms (18)  ·  Neutropenia (18)  ·  Anemia, Sickle Cell (17)  ·  Myelodysplastic Syndromes (17)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (16)

Broader conditions

Hemic and Lymphatic Diseases (486)  ·  Pathological Conditions, Signs and Symptoms (147)  ·  Neoplasms (130)  ·  Pathologic Processes (123)  ·  Neoplasms by Histologic Type (121)  ·  Immune System Diseases (116)  ·  Hemorrhagic Disorders (106)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (101)  ·  Genetic Diseases, Inborn (97)  ·  Anemia (91)  ·  Nutritional and Metabolic Diseases (79)  ·  Metabolic Diseases (75)  ·  Immunoproliferative Disorders (72)  ·  Lymphoproliferative Disorders (72)

Interventions

Cytarabine (20)  ·  ferric carboxymaltose (20)  ·  Factor VIII (19)  ·  Cyclophosphamide (16)  ·  Dexamethasone (16)  ·  Vincristine (16)  ·  epoetin beta (16)  ·  Darbepoetin alfa (15)  ·  Methotrexate (15)  ·  Epoetin Alfa (14)  ·  ferrous sulfate (14)  ·  Mercaptopurine (12)  ·  Asparaginase (11)  ·  Saline Solution (11)  ·  continuous erythropoietin receptor activator (11)

Sponsors

Novartis Pharmaceuticals (27)  ·  Hoffmann-La Roche (19)  ·  PETHEMA Foundation (18)  ·  Amgen (15)  ·  Pfizer (11)  ·  Baxalta now part of Shire (9)  ·  Bayer (7)  ·  Watson Pharmaceuticals (7)  ·  Goethe University (6)  ·  Ain Shams University (5)  ·  AstraZeneca (5)  ·  Institute of Hematology & Blood Diseases Hospital, China (5)  ·  Assiut University (4)  ·  CSL Behring (4)  ·  GlaxoSmithKline (4)

Countries

United States (111)  ·  China (45)  ·  Spain (43)  ·  Germany (39)  ·  France (31)  ·  United Kingdom (27)  ·  Italy (25)  ·  Egypt (21)  ·  India (20)  ·  Canada (17)  ·  Poland (16)  ·  Belgium (14)  ·  Sweden (14)  ·  Turkey (Türkiye) (13)  ·  Switzerland (12)

Top investigators

Dieter Hoelzer, MD,PhD (4)  ·  Sanz Miguel Angel, Dr (4)  ·  Shuhua Yi, Doc (3)  ·  Adel R. Rizkala, Pharm.D., MS (2)  ·  Bastida Pilar, Dr (2)

Results publications

PMID 36791280, PMID 18328118, PMID 34932836, PMID 36064577, PMID 41114449, PMID 18828899, PMID 19144982, PMID 19208097, PMID 22442346, PMID 22493293, PMID 23024237, PMID 24363761, PMID 24923295, PMID 26504182, PMID 27561722, PMID 27881371, PMID 28751559, PMID 28945881, PMID 12045120, PMID 14616423, PMID 14752084, PMID 15014526, PMID 15158091, PMID 15257960, PMID 15953714, PMID 16177289, PMID 16273116, PMID 16520948, PMID 16614237, PMID 16737942, PMID 16977654, PMID 17035697, PMID 17223475, PMID 17267740, PMID 17296819, PMID 17396118, PMID 17400086, PMID 17470691, PMID 17522247, PMID 17621407, PMID 17622274, PMID 17694552, PMID 17962803, PMID 18008242, PMID 18056840, PMID 18067679, PMID 18165618, PMID 18216316, PMID 18284320, PMID 18343652

NIH funding

2009 (8), 2014 (4), 2015 (4), 2016 (4), 2018 (4), 2005 (3), 2008 (3), 2019 (3), 2017 (2), 2023 (2), 2004 (1), P30AI060354 (1), P30CA021765 (1), R01CA078957 (1), R01CA091912 (1)